StockData
Fractyl Health, Inc. logo

Fractyl Health, Inc. (GUTS) stock

GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.08+0.11 (+11.87%)

Close on Nov 18, 2026Market cap $171.91MP/E –Yield –

Fractyl Health r&d expenses

Research and development expenses are spending on new products and technology.

Fractyl Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $63.36M, down 20.7% year over year. For fiscal 2025 it was $74.54M, up 5.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.54M+5.8%
FY2024Dec 31, 2024$70.47M+85.3%
FY2023Dec 31, 2023$38.04M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.81M-34.7%
Q1 FY2026Mar 31, 2026$15.60M-19.7%
Q4 FY2025Dec 31, 2025$16.49M-18.7%
Q3 FY2025Sep 30, 2025$17.46M-8.1%
Q2 FY2025Jun 30, 2025$21.15M+26.2%
Q1 FY2025Mar 31, 2025$19.44M+34.7%
Q4 FY2024Dec 31, 2024$20.28M+99.5%
Q3 FY2024Sep 30, 2024$19.00M+102.6%
Q2 FY2024Jun 30, 2024$16.76M+83.4%
Q1 FY2024Mar 31, 2024$14.42M+54.3%
Q4 FY2023Dec 31, 2023$10.17M–
Q3 FY2023Sep 30, 2023$9.38M–
Q2 FY2023Jun 30, 2023$9.14M–
Q1 FY2023Mar 31, 2023$9.35M–

More Fractyl Health figures

See a number that looks wrong?